[-] Show simple item record

dc.contributor.authorCrosby, Kimberlyeng
dc.contributor.authorBigelow, Simoneeng
dc.contributor.authorSachs, Vivianeeng
dc.contributor.authorWeakley, Jennifereng
dc.contributor.authorSkaftason, Helgaeng
dc.contributor.authorHoberecht, Tonieng
dc.date.issued2022-09eng
dc.description.abstractQ: What barriers delay treatment in patients with hepatitis C? Evidence-based answer: Multiple patient-specific and provider-perceived factors delay initiation of treatment in patients with hepatitis C. Patient-specific barriers to initiation of treatment for hepatitis C virus (HCV) include age, race, gender, economic status, insurance status, and comorbidities such as HIV coinfection, psychiatric illness, and other psychosocial factors. Provider-perceived patient factors include substance abuse history, older age, psychiatric illness, medical comorbidities, treatment adverse effect risks, and factors that might limit adherence (eg, comprehension level). Study limitations included problems with generalizability of the populations studied and variability in reporting or interpreting data associated with substance or alcohol use disorders (strength of recommendation: B, based on 2 prospective and 5 retrospective cohort studies).eng
dc.description.bibrefIncludes bibliographical referenceseng
dc.description.statementofresponsibilityKimberly Crosby, PharmD; Simone Bigelow, DO; Viviane Sachs, MD; Jennifer Weakley, MD; Helga Skaftason, MD, MPH University of Oklahoma School of Community Medicine, Department of Family and Community Medicine, Tulsa Toni Hoberecht, MA, MLIS, AHIP University of Oklahoma-- Tulsa, Schusterman Libraryeng
dc.format.extent3 pageseng
dc.identifier.citationThe journal of family practice 71 (7) 2022 E22-E24eng
dc.identifier.urihttps://hdl.handle.net/10355/91991
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofcollectionClinical Inquiries, 2022 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri--Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.titleWhat barriers delay treatment in patients with hepatitis C?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record